Oxford Biomedica Plc Stock Current Valuation
| OXBDF Stock | USD 2.72 0.10 3.82% |
Valuation analysis of Oxford Biomedica plc helps investors to measure Oxford Biomedica's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Oxford Biomedica's price fluctuation is risky at this time. Calculation of the real value of Oxford Biomedica plc is based on 3 months time horizon. Increasing Oxford Biomedica's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Oxford Biomedica plc is useful when determining the fair value of the Oxford pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Oxford Biomedica. Since Oxford Biomedica is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Oxford Pink Sheet. However, Oxford Biomedica's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.72 | Real 2.15 | Hype 2.72 |
The real value of Oxford Pink Sheet, also known as its intrinsic value, is the underlying worth of Oxford Biomedica plc Company, which is reflected in its stock price. It is based on Oxford Biomedica's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Oxford Biomedica's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Oxford Biomedica's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Oxford Biomedica plc helps investors to forecast how Oxford pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Oxford Biomedica more accurately as focusing exclusively on Oxford Biomedica's fundamentals will not take into account other important factors: Oxford Biomedica plc Company Current Valuation Analysis
Oxford Biomedica's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Oxford Biomedica Current Valuation | 436.12 M |
Most of Oxford Biomedica's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oxford Biomedica plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Oxford Biomedica plc has a Current Valuation of 436.12 M. This is 96.96% lower than that of the Healthcare sector and 90.61% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 97.38% higher than that of the company.
Oxford Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oxford Biomedica's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Oxford Biomedica could also be used in its relative valuation, which is a method of valuing Oxford Biomedica by comparing valuation metrics of similar companies.Oxford Biomedica is currently under evaluation in current valuation category among related companies.
Oxford Fundamentals
| Return On Equity | -0.14 | |||
| Return On Asset | -0.024 | |||
| Profit Margin | (0.20) % | |||
| Operating Margin | (0.10) % | |||
| Current Valuation | 436.12 M | |||
| Shares Outstanding | 96.27 M | |||
| Shares Owned By Insiders | 6.19 % | |||
| Shares Owned By Institutions | 62.89 % | |||
| Price To Earning | 17.67 X | |||
| Price To Book | 1.69 X | |||
| Price To Sales | 3.60 X | |||
| Revenue | 142.8 M | |||
| Gross Profit | 82.64 M | |||
| EBITDA | 33.22 M | |||
| Net Income | 19.01 M | |||
| Cash And Equivalents | 118.55 M | |||
| Cash Per Share | 1.23 X | |||
| Total Debt | 107.5 M | |||
| Debt To Equity | 0.41 % | |||
| Current Ratio | 1.83 X | |||
| Book Value Per Share | 2.31 X | |||
| Cash Flow From Operations | 25.45 M | |||
| Earnings Per Share | 0.24 X | |||
| Number Of Employees | 959 | |||
| Beta | 0.97 | |||
| Market Capitalization | 548.76 M | |||
| Total Asset | 237.23 M | |||
| Working Capital | 12.54 M | |||
| Current Asset | 25.71 M | |||
| Current Liabilities | 13.17 M | |||
| Z Score | 3.0 | |||
| Net Asset | 237.23 M |
About Oxford Biomedica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oxford Biomedica plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oxford Biomedica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oxford Biomedica plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oxford Biomedica plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Oxford Biomedica plc information on this page should be used as a complementary analysis to other Oxford Biomedica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Oxford Pink Sheet analysis
When running Oxford Biomedica's price analysis, check to measure Oxford Biomedica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oxford Biomedica is operating at the current time. Most of Oxford Biomedica's value examination focuses on studying past and present price action to predict the probability of Oxford Biomedica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oxford Biomedica's price. Additionally, you may evaluate how the addition of Oxford Biomedica to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |